Team led by Sunney Xie, the director of its Beijing Advanced Innovation Centre for Genomics, has successfully identified multiple highly potent neutralising antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19 from convalescent plasma [a blood fluid] by high-throughput single-cell sequencing, Peking University in Beijing said on Monday. National Herald
Wednesday, May 20, 2020
COVID-19: Drug being tested in China may offer short term immunity to the virus
Team led by Sunney Xie, the director of its Beijing Advanced Innovation Centre for Genomics, has successfully identified multiple highly potent neutralising antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19 from convalescent plasma [a blood fluid] by high-throughput single-cell sequencing, Peking University in Beijing said on Monday. National Herald
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment